Clinical Trial Update: TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion" [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the use of beta-blockers after myocardial infarction with preserved ejection fraction; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• beta-blockers (beta-adrenergic blocker)

Snippet

Sponsor: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III | Conditions: Myocardial Infarction | Phase 4 | Status: COMPLETED